| Fatima Ababon, | |
|
177 Remsen Ave, Avenel, NJ 07001-1258 | |
| (201) 360-1240 | |
| (720) 294-3788 |
| Full Name | Fatima Ababon |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 177 Remsen Ave, Avenel, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346699063 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR11163700 (New Jersey) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 26NJ01122000 (New Jersey) | Primary |
| Entity Name | Garden State Healthcare Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700014545 PECOS PAC ID: 8426190687 Enrollment ID: O20100126000693 |
News Archive
Generex Biotechnology Corporation today announced presentation of additional results from a recently completed Phase I clinical trial of its novel immunotherapeutic peptide AE37 in prostate cancer patients. AE37 is a synthetic cancer vaccine being developed by Antigen Express, Inc., a wholly owned subsidiary of Generex, for multiple cancer indications.
Therapy that involves the parents in the treatment of children with disruptive behavior disorders shows the best results compared to more than 20 other therapeutic approaches, according to a new study published today in the Journal of Clinical Child and Adolescent Psychology, a journal of the Society of Clinical Child and Adolescent Psychology.
Lucideon, the international provider of materials development, testing and assurance, and formerly known as Ceram and M+P Labs, has added wear testing and debris analysis to its services for orthopaedic implant manufacturers across Europe and the US.
GenMark Diagnostics Inc. announced today that it has dismissed a lawsuit in the Northern District of California pending since November 2010 that requested declaratory relief that it does not infringe three U.S. patents on microfluidic technology allegedly owned by Caliper Life Sciences, Inc.
› Verified 5 days ago
| Entity Name | Oak Tree Healthcare Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083368674 PECOS PAC ID: 0941695860 Enrollment ID: O20220311000654 |
News Archive
Generex Biotechnology Corporation today announced presentation of additional results from a recently completed Phase I clinical trial of its novel immunotherapeutic peptide AE37 in prostate cancer patients. AE37 is a synthetic cancer vaccine being developed by Antigen Express, Inc., a wholly owned subsidiary of Generex, for multiple cancer indications.
Therapy that involves the parents in the treatment of children with disruptive behavior disorders shows the best results compared to more than 20 other therapeutic approaches, according to a new study published today in the Journal of Clinical Child and Adolescent Psychology, a journal of the Society of Clinical Child and Adolescent Psychology.
Lucideon, the international provider of materials development, testing and assurance, and formerly known as Ceram and M+P Labs, has added wear testing and debris analysis to its services for orthopaedic implant manufacturers across Europe and the US.
GenMark Diagnostics Inc. announced today that it has dismissed a lawsuit in the Northern District of California pending since November 2010 that requested declaratory relief that it does not infringe three U.S. patents on microfluidic technology allegedly owned by Caliper Life Sciences, Inc.
› Verified 5 days ago
| Entity Name | Ihpnj Er Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225750946 PECOS PAC ID: 3870963168 Enrollment ID: O20230103000314 |
News Archive
Generex Biotechnology Corporation today announced presentation of additional results from a recently completed Phase I clinical trial of its novel immunotherapeutic peptide AE37 in prostate cancer patients. AE37 is a synthetic cancer vaccine being developed by Antigen Express, Inc., a wholly owned subsidiary of Generex, for multiple cancer indications.
Therapy that involves the parents in the treatment of children with disruptive behavior disorders shows the best results compared to more than 20 other therapeutic approaches, according to a new study published today in the Journal of Clinical Child and Adolescent Psychology, a journal of the Society of Clinical Child and Adolescent Psychology.
Lucideon, the international provider of materials development, testing and assurance, and formerly known as Ceram and M+P Labs, has added wear testing and debris analysis to its services for orthopaedic implant manufacturers across Europe and the US.
GenMark Diagnostics Inc. announced today that it has dismissed a lawsuit in the Northern District of California pending since November 2010 that requested declaratory relief that it does not infringe three U.S. patents on microfluidic technology allegedly owned by Caliper Life Sciences, Inc.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Fatima Ababon, 177 Remsen Ave, Avenel, NJ 07001-1258 Ph: (201) 779-4763 | Fatima Ababon, 177 Remsen Ave, Avenel, NJ 07001-1258 Ph: (201) 360-1240 |
News Archive
Generex Biotechnology Corporation today announced presentation of additional results from a recently completed Phase I clinical trial of its novel immunotherapeutic peptide AE37 in prostate cancer patients. AE37 is a synthetic cancer vaccine being developed by Antigen Express, Inc., a wholly owned subsidiary of Generex, for multiple cancer indications.
Therapy that involves the parents in the treatment of children with disruptive behavior disorders shows the best results compared to more than 20 other therapeutic approaches, according to a new study published today in the Journal of Clinical Child and Adolescent Psychology, a journal of the Society of Clinical Child and Adolescent Psychology.
Lucideon, the international provider of materials development, testing and assurance, and formerly known as Ceram and M+P Labs, has added wear testing and debris analysis to its services for orthopaedic implant manufacturers across Europe and the US.
GenMark Diagnostics Inc. announced today that it has dismissed a lawsuit in the Northern District of California pending since November 2010 that requested declaratory relief that it does not infringe three U.S. patents on microfluidic technology allegedly owned by Caliper Life Sciences, Inc.
› Verified 5 days ago
Amirah J Brack, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1804 Forest View Dr, Avenel, NJ 07001 Phone: 908-361-3224 | |
Lori Mido, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 89 Woodbine Ave, Avenel, NJ 07001 Phone: 732-602-8524 | |
Nataliya Lizanets, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1030 Saint Georges Ave Ste 302, Avenel, NJ 07001 Phone: 732-750-1200 | |
Mrs. Violet Christopher Monis, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 62 Remsen Ave, Avenel, NJ 07001 Phone: 848-248-1152 | |
Julia Burton, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 151 Piper Ave, Unit 108, Avenel, NJ 07001 Phone: 850-443-4690 | |
Firmin Langyin, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 200 Station Dr Apt 207, Avenel, NJ 07001 Phone: 862-944-2913 | |
Mrs. Geraldine Dolan, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1030 Saint Georges Ave, Ste 201, Avenel, NJ 07001 Phone: 732-602-0244 |